Pharmaceuticals, Biotechnology and Life Sciences
Advanced Oncotherapy , the developer of proton therapy systems for cancer treatment, has announced on Tuesday that planning permission for the Harley Street site was granted.
SuperSonic Imagine has announced its sales for the third quarter to September 30, 2016.
KEOPSYS Group holding company, acquired for € 5 million, 93.8% of the capital of EURODYNE, which holds 1,184,513 QUANTEL shares and 1,928,579 voting rights, representing 14.6% of the capital and 21.3% of the voting rights of QUANTEL.
Johnson & Johnson has reported on Tuesday net earnings and diluted earnings per share for the third quarter of 2016 of$4.3 billion and $1.53, respectively. Third quarter 2015 net earnings included …
EOS imaging announced the recent entry into the North African market with the opening of two EOS sites in Tunisia.
TxCell SA has appointed Li Zhou, PhD, as Vice President, Cell Engineering.
SAFE ORTHOPAEDICS has released its revenue for the first nine months of 2016 at September 30, 2016.
The net result over the first six months of 2016 was a loss of €1,028K compared to a loss of €872K in H1 2015.
Horizon Pharma, with its wholly owned subsidiaries, Horizon Pharma, Inc. and Horizon Pharma USA, Inc., intends to offer $300 million aggregate principal amount of senior notes due 2024, and to borrow $375 million.
THERADIAG a company specializing in in vitro diagnostics and theranostics, has reported its consolidated revenues for the 3rd quarter of 2016.